Fairvalue-Calculator Fairvalue-Calculator
EN DE

Pluri Inc (PLUR) Fair Value & Analysis

Healthcare · US · Market cap $21.8M

Price$2.02
Fair Value$0.4300
Upside-78.7%
Quality80/100
Evidence: Low Range $0.3300 – $0.5400

Fair value as of: Jun 23, 2026

Analysis

Pluri Inc (PLUR) currently trades at $2.02, while our model-based Fair Value estimate is $0.4300 — implying the stock looks roughly 78.7% overvalued today. We read business quality at 80/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Pluri Inc., a biotechnology company, engages in the research, development, and manufacture of cell-based products, cell therapeutics, and related technologies for various industries. The company develops placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions; and immunotherapy platform. Its product candidates include PLX-PAD, that is composed of maternal mesenchymal stromal cells originating from the placenta for the treatment of various indications, such as acute muscle injuries following hip fracture, acute respiratory distress syndrome due to coronavirus Disease (COVID-19), peripheral artery disease, intermittent claudication, and critical limb ischemia; PLX-R18, composed of fetal MSC like cells originating from the placenta for the treatment of hematopoietic complications of the H-ARS, and is in Phase I clinical trial to treat hematopoietic cell transplantation; and allogeneic MAIT cell therapy platform. The …

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -38% Regeneron Pharmaceuticals, Inc (REGN) -14% UCB SA (UCB) -28% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) -28% Alnylam Pharmaceuticals, Inc (ALNY) -63%

Frequently asked questions

Is Pluri Inc (PLUR) undervalued?
As of Jun 23, 2026, our model estimates a fair value of $0.4300 versus a price of $2.02 — about −79% (overvalued). Model-based estimate, not financial advice.
What is the fair value of PLUR?
Our 21-model fair value for Pluri Inc is $0.4300 (as of Jun 23, 2026), built from audited fundamentals. The current price is $2.02.
What is the quality score of PLUR?
Pluri Inc has a Quality Score of 80/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.